BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, January 26, 2026
See today's BioWorld
Home
» Agile's Twirla struggles to impress ahead of FDA adcom date
To read the full story,
subscribe
or
sign in
.
Agile's Twirla struggles to impress ahead of FDA adcom date
Oct. 29, 2019
By
Mari Serebrov
The third time is proving not to be so charming for
Agile Therapeutics Inc.
as it prepares its lead candidate for a date Wednesday with the FDA's Bone, Reproductive and Urologic Drugs Advisory Committee.
BioWorld
U.S.